Bringing the very best science and medicine to our best equine friends
June 14, 2016

Kindred Biosciences Announces Initiation of Pilot Field Study of Atopic Dermatitis and Other Updates

San Francisco, CA (June 14, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced the initiation of a pilot field study designed to test several molecules, including anti-cytokine antibodies, in dogs with atopic dermatitis. The pilot field study in dogs with atopic dermatitis is a multi-center pilot study to assess safety and efficacy of several molecules, and to determine the candidate(s) that will be taken into further development. In addition, KindredBio provided an update on its equine biologics program. The first stage of a pilot field study in sick or …

Continue Reading